Equities

Standard BioTools Inc

Standard BioTools Inc

Actions
  • Price (EUR)2.02
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change+8.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments11516628
Total Receivables, Net201718
Total Inventory212121
Prepaid expenses3.133.263.45
Other current assets, total--1.021.02
Total current assets15820972
Property, plant & equipment, net556065
Goodwill, net106106106
Intangibles, net1.411329
Long term investments------
Note receivable - long term------
Other long term assets1.481.531.43
Total assets323390275
LIABILITIES
Accounts payable9.247.9111
Accrued expenses251917
Notes payable/short-term debt000
Current portion long-term debt/capital leases602.086.84
Other current liabilities, total161415
Total current liabilities1094350
Total long term debt3.986364
Total debt646571
Deferred income tax0.841.064.33
Minority interest------
Other liabilities, total465363
Total liabilities160161181
SHAREHOLDERS EQUITY
Common stock0.080.080.08
Additional paid-in capital861847831
Retained earnings (accumulated deficit)(1001)(926)(736)
Treasury stock - common(5.98)(0.56)--
Unrealized gain (loss)--(0.5)--
Other equity, total(2.22)(1.39)(0.91)
Total equity16323095
Total liabilities & shareholders' equity323390275
Total common shares outstanding807977
Treasury shares - common primary issue3.130.420
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.